Finance

Lists
SILO:IDX
Siloam International Hospitals Tbk PT
IDR 2 030,00
-0,98%
(-20,00) 1D
1 Okt., 16:08:13 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for SILO...
Open
IDR 2 060
High
IDR 2 080
Low
IDR 1 990
Mkt. cap
26,40 bn
Avg. vol.
1,35 m
Volume
700,10 k
P/E ratio
21,32
52-wk high
IDR 2 880
52-wk low
IDR 1 830
EPS
IDR 95
Shares outstanding
13,01 mjd
No. of employees
15 k
Open
IDR 2 060
High
IDR 2 080
Low
IDR 1 990
Mkt. cap
26,40 bn
Avg. vol.
1,35 m
Volume
700,10 k
P/E ratio
21,32
52-wk high
IDR 2 880
52-wk low
IDR 1 830
EPS
IDR 95
Shares outstanding
13,01 mjd
No. of employees
15 k
News stories
From web sources and news partners
Profile
PT Siloam International Hospitals Tbk or Siloam Hospitals is a chain of healthcare facilities in Indonesia founded in 1996 by PT. Lippo Karawaci Tbk. It is a publicly listed company which is part of Lippo Group. Wikipedia
About Siloam International Hospitals Tbk PT
CEO-
Employees14,7 k
Founded27 Aug. 1996
HeadquartersTangerang, Banten, Indonesië
SectorHealth care provider
Last report
30 Jul. 2026
Fiscal period
Q2 2026
EPS / Est. (IDR)
- / -
Revenue / Est. (IDR)
3,49 bn / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
3,32 bn
3,42 bn
3,28 bn
3,49 bn
Cost of goods sold
2,08 bn
2,10 bn
2,08 bn
2,21 bn
Cost of revenue
2,08 bn
2,10 bn
2,08 bn
2,21 bn
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
722,64 mjd
738,98 mjd
738,36 mjd
755,42 mjd
Operating expense
769,58 mjd
801,39 mjd
776,68 mjd
813,06 mjd
Total operating expenses
2,85 bn
2,91 bn
2,86 bn
3,02 bn
Operating income
470,34 mjd
516,10 mjd
421,50 mjd
464,75 mjd
Other non operating income
-6,84 mjd
-9,94 mjd
-9,34 mjd
-11,36 mjd
EBT including unusual items
428,16 mjd
475,15 mjd
382,93 mjd
422,51 mjd
EBT excluding unusual items
428,16 mjd
475,15 mjd
382,93 mjd
422,51 mjd
Income tax expense
107,46 mjd
108,10 mjd
89,35 mjd
106,62 mjd
Effective tax rate
25,10%
22,75%
23,33%
25,24%
Other operating expenses
46,94 mjd
62,41 mjd
38,32 mjd
57,64 mjd
Net income
304,52 mjd
351,32 mjd
279,97 mjd
300,71 mjd
Net profit margin
9,17%
10,27%
8,54%
8,63%
Earnings per share
-
-
-
-
Interest and investment income
3,94 mjd
5,88 mjd
6,44 mjd
8,53 mjd
Interest expense
-30,42 mjd
-27,88 mjd
-26,99 mjd
-31,43 mjd
Net interest expenses
-26,49 mjd
-22,00 mjd
-20,55 mjd
-22,89 mjd
Depreciation and amortization charges
-
-
-
-
EBITDA
595,74 mjd
643,43 mjd
563,11 mjd
612,54 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme